Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_2
1
14%
Ph phase_3
2
29%
Ph not_applicable
2
29%
Ph phase_4
2
29%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 32 (28.6%)
Phase 42 (28.6%)
N/A2 (28.6%)

Trials by Status

completed7100%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

NCT00622843
completedphase_3

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

NCT05028634
completedphase_2

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

NCT00788151
completednot_applicable

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients

NCT02547493
completednot_applicable

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs

NCT00257127
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00622843Phase 3

Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting

Completed
NCT05028634Phase 3

Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy

Completed
NCT00788151Phase 2

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

Completed
NCT02547493Not Applicable

Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients

Completed
NCT00257127Not Applicable

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs

Completed
NCT01402245Phase 4

Targeting of Immune Response After Pneumococcal Vaccination

Completed
NCT00964769Phase 4

Study of Evaluation Indexes for Antibody Production in Sera After Immunization

Completed

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7